Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. (Q42493451)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. |
scientific article |
Statements
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients (English)
Annalisa Giardinelli
Vittorio Sirolli
Chiara Riganti
Pamela Di Tomo
Elena Gazzano
Sara Di Silvestre
Csaba Csonka
Péter Ferdinandy
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference